Sign inGet started

KNTE

Kinnate Biopharma Inc.CIK 1797768 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21

AI insights for KNTE PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for KNTE
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
OrbiMed Asia GP IV, L.P.Director, 10% Owner5$0$02024-04-03
DeSimone JillDirector2$0$02024-04-03
Krishnamohan NehaChief Financial Officer14$0$02024-04-03
Rome Michael EDirector4$0$02024-04-03
Farzan NimaChief Executive Officer10$0$02024-04-03
Epperly Melissa B,Director7$0$02024-04-03
Foresite Capital Opportunity Fund V, L.P.10% Owner3$0$02024-04-03
Meltz Mark ACOO General Counsel Treasurer16$0$02024-04-03
Sabzevari HelenDirector6$0$02024-04-03
Smaldone Alsup LaurieDirector7$0$02024-04-03
Tananbaum James B.Director, 10% Owner25$24.98M$02024-04-03
Flaherty Keith T.Director10$0$02024-04-03
GORDON CARL LDirector, 10% Owner45$24.75M$02024-04-03
MITCHELL DEAN JDirector7$0$02024-04-03
Williams Richard ThomasChief Medical Officer12$338.9K$02024-03-01
Foresite Capital Management IV, LLC10% Owner18$4.98M$02023-05-08
ORBIMED ADVISORS LLCDirector, 10% Owner7$19.09M$02023-05-05
OrbiMed Capital GP VII LLCDirector, 10% Owner9$3.67M$02023-05-02
OrbiMed Genesis GP LLCDirector, 10% Owner6$1.99M$02023-02-17
Murphy Eric AnthonyChief Scientific Officer1$0$02021-02-12
ORBIMED CAPITAL LLCDirector, 10% Owner12$0$02020-12-07

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
GORDON CARL LDirector, 10% Owner D To issuer deriv2024-04-032024-04-0540,501— $00SEC↗
GORDON CARL LDirector, 10% Owner D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
GORDON CARL LDirector, 10% Owner D To issuer deriv2024-04-032024-04-0525,000— $00SEC↗
Meltz Mark ACOO GENERAL COUNSEL SECRETAR D To issuer deriv2024-04-032024-04-05121,503— $00SEC↗
Meltz Mark ACOO GENERAL COUNSEL SECRETAR D To issuer deriv2024-04-032024-04-05215,000— $00SEC↗
Meltz Mark ACOO GENERAL COUNSEL SECRETAR D To issuer deriv2024-04-032024-04-05135,000— $00SEC↗
Meltz Mark ACOO GENERAL COUNSEL SECRETAR D To issuer deriv2024-04-032024-04-05384,508— $00SEC↗
Meltz Mark ACOO GENERAL COUNSEL SECRETAR D To issuer deriv2024-04-032024-04-05100,000— $00SEC↗
DeSimone JillDirector D To issuer deriv2024-04-032024-04-0550,000— $00SEC↗
Sabzevari HelenDirector D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
Sabzevari HelenDirector D To issuer deriv2024-04-032024-04-0540,501— $00SEC↗
Sabzevari HelenDirector D To issuer deriv2024-04-032024-04-0525,000— $00SEC↗
Rome Michael EDirector D To issuer deriv2024-04-032024-04-0540,501— $00SEC↗
Rome Michael EDirector D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
Flaherty Keith T.Director D To issuer deriv2024-04-032024-04-0511,391— $00SEC↗
Flaherty Keith T.Director D To issuer deriv2024-04-032024-04-0556,112— $00SEC↗
Flaherty Keith T.Director D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
Flaherty Keith T.Director D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
Flaherty Keith T.Director D To issuer deriv2024-04-032024-04-0532,064— $00SEC↗
Flaherty Keith T.Director D To issuer deriv2024-04-032024-04-0525,000— $00SEC↗
Epperly Melissa B,Director D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
Epperly Melissa B,Director D To issuer deriv2024-04-032024-04-0525,000— $00SEC↗
Epperly Melissa B,Director D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
Epperly Melissa B,Director D To issuer deriv2024-04-032024-04-0560,751— $00SEC↗
Smaldone Alsup LaurieDirector D To issuer deriv2024-04-032024-04-0560,751— $00SEC↗
Smaldone Alsup LaurieDirector D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
Smaldone Alsup LaurieDirector D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
Smaldone Alsup LaurieDirector D To issuer deriv2024-04-032024-04-0525,000— $00SEC↗
Krishnamohan NehaCHIEF FINANCIAL OFFICER D To issuer deriv2024-04-032024-04-05185,000— $00SEC↗
Krishnamohan NehaCHIEF FINANCIAL OFFICER D To issuer deriv2024-04-032024-04-05215,000— $00SEC↗
Krishnamohan NehaCHIEF FINANCIAL OFFICER D To issuer deriv2024-04-032024-04-05270,000— $00SEC↗
MITCHELL DEAN JDirector D To issuer deriv2024-04-032024-04-05121,503— $00SEC↗
MITCHELL DEAN JDirector D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
MITCHELL DEAN JDirector D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
MITCHELL DEAN JDirector D To issuer deriv2024-04-032024-04-0525,000— $00SEC↗
Farzan NimaCHIEF EXECUTIVE OFFICER D To issuer deriv2024-04-032024-04-05400,000— $00SEC↗
Farzan NimaCHIEF EXECUTIVE OFFICER D To issuer deriv2024-04-032024-04-05275,000— $00SEC↗
Farzan NimaCHIEF EXECUTIVE OFFICER D To issuer deriv2024-04-032024-04-05750,000— $00SEC↗
Farzan NimaCHIEF EXECUTIVE OFFICER D To issuer deriv2024-04-032024-04-051,281,642— $00SEC↗
Farzan NimaCHIEF EXECUTIVE OFFICER D To issuer deriv2024-04-032024-04-05437,413— $00SEC↗
Tananbaum James B.Director, 10% Owner D To issuer deriv2024-04-032024-04-0520,250— $00SEC↗
Tananbaum James B.Director, 10% Owner D To issuer deriv2024-04-032024-04-0540,501— $00SEC↗
Foresite Capital Opportunity F10% Owner D To issuer2024-04-032024-04-059,671,643— $00SEC↗
Foresite Capital Opportunity F10% Owner D To issuer2024-04-032024-04-05520,711— $00SEC↗
Foresite Capital Opportunity F10% Owner D To issuer2024-04-032024-04-053,525,957— $00SEC↗
OrbiMed Asia GP IV, L.P.Director, 10% Owner D To issuer2024-04-032024-04-0584,599— $00SEC↗
OrbiMed Asia GP IV, L.P.Director, 10% Owner D To issuer2024-04-032024-04-05450,000— $00SEC↗
OrbiMed Asia GP IV, L.P.Director, 10% Owner D To issuer2024-04-032024-04-051,368,338— $00SEC↗
OrbiMed Asia GP IV, L.P.Director, 10% Owner D To issuer2024-04-032024-04-051,368,339— $00SEC↗
OrbiMed Asia GP IV, L.P.Director, 10% Owner D To issuer2024-04-032024-04-054,738,453— $00SEC↗
GORDON CARL LDirector, 10% Owner D To issuer2024-04-032024-04-051,368,339— $00SEC↗
GORDON CARL LDirector, 10% Owner D To issuer2024-04-032024-04-05450,000— $00SEC↗
GORDON CARL LDirector, 10% Owner D To issuer2024-04-032024-04-0584,599— $00SEC↗
GORDON CARL LDirector, 10% Owner D To issuer2024-04-032024-04-051,368,338— $00SEC↗
GORDON CARL LDirector, 10% Owner D To issuer2024-04-032024-04-054,738,453— $00SEC↗
Meltz Mark ACOO GENERAL COUNSEL SECRETAR D To issuer2024-04-032024-04-0527,578— $00SEC↗
Flaherty Keith T.Director D To issuer2024-04-032024-04-0566,377— $00SEC↗
Krishnamohan NehaCHIEF FINANCIAL OFFICER D To issuer2024-04-032024-04-0564,087— $00SEC↗
Farzan NimaCHIEF EXECUTIVE OFFICER D To issuer2024-04-032024-04-052,186— $00SEC↗
Tananbaum James B.Director, 10% Owner D To issuer2024-04-032024-04-059,671,643— $00SEC↗
Tananbaum James B.Director, 10% Owner D To issuer2024-04-032024-04-053,525,957— $00SEC↗
Tananbaum James B.Director, 10% Owner D To issuer2024-04-032024-04-05520,711— $00SEC↗
Meltz Mark ACOO GENERAL COUNSEL SECRETAR F Tax w/h2024-03-012024-03-05558$2.59 $1.4K27,578SEC↗
Williams Richard ThomasCHIEF MEDICAL OFFICER F Tax w/h2024-03-012024-03-05558$2.59 $1.4K67,588SEC↗
Krishnamohan NehaCHIEF FINANCIAL OFFICER F Tax w/h2024-03-012024-03-051,506$2.59 $3.9K64,087SEC↗
Meltz Mark ACOO General Counsel Secretar F Tax w/h2023-12-012023-12-05541$2.25 $1.2K28,136SEC↗
Krishnamohan NehaChief Financial Officer F Tax w/h2023-12-012023-12-051,459$2.25 $3.3K65,593SEC↗
Williams Richard ThomasChief Medical Officer F Tax w/h2023-12-012023-12-05541$2.25 $1.2K68,146SEC↗
Williams Richard ThomasChief Medical Officer F Tax w/h2023-09-012023-09-06541$2.35 $1.3K68,687SEC↗
Meltz Mark ACOO General Counsel Secretar F Tax w/h2023-09-012023-09-06541$2.35 $1.3K28,677SEC↗
Krishnamohan NehaChief Financial Officer F Tax w/h2023-09-012023-09-061,459$2.35 $3.4K67,052SEC↗
Epperly Melissa B,Director A Award deriv2023-06-122023-06-1325,000— $025,000SEC↗
Flaherty Keith T.Director A Award deriv2023-06-122023-06-1325,000— $025,000SEC↗
GORDON CARL LDirector, 10% Owner A Award deriv2023-06-122023-06-1325,000— $025,000SEC↗
MITCHELL DEAN JDirector A Award deriv2023-06-122023-06-1325,000— $025,000SEC↗
Smaldone Alsup LaurieDirector A Award deriv2023-06-122023-06-1325,000— $025,000SEC↗
Sabzevari HelenDirector A Award deriv2023-06-122023-06-1325,000— $025,000SEC↗
Meltz Mark ACOO General Counsel Secretar F Tax w/h2023-06-012023-06-05541$4.30 $2.3K29,218SEC↗
Williams Richard ThomasChief Medical Officer F Tax w/h2023-06-012023-06-05541$4.30 $2.3K69,228SEC↗
Krishnamohan NehaChief Financial Officer F Tax w/h2023-06-012023-06-051,459$4.30 $6.3K68,511SEC↗
Foresite Capital Management IV10% Owner P Buy2023-05-082023-05-10229,044$2.80 $641.3K520,711SEC↗
Foresite Capital Management IV10% Owner P Buy2023-05-082023-05-101,550,956$2.80 $4.34M3,525,957SEC↗
Tananbaum James B.Director, 10% Owner P Buy2023-05-082023-05-101,550,956$2.80 $4.34M3,525,957SEC↗
Tananbaum James B.Director, 10% Owner P Buy2023-05-082023-05-10229,044$2.80 $641.3K520,711SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-052023-05-08490,511$2.82 $1.38M1,368,338SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-052023-05-08490,512$2.82 $1.38M1,368,339SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner P Buy2023-05-052023-05-08490,512$2.82 $1.38M1,368,339SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner P Buy2023-05-052023-05-08490,511$2.82 $1.38M1,368,338SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-042023-05-0883,459$2.75 $229.5K877,827SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-042023-05-0883,459$2.75 $229.5K877,827SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-042023-05-08312,991$2.75 $860.7K4,738,453SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner P Buy2023-05-042023-05-08312,991$2.75 $860.7K4,738,453SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner P Buy2023-05-042023-05-0883,459$2.75 $229.5K877,827SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner P Buy2023-05-042023-05-0883,459$2.75 $229.5K877,827SEC↗
OrbiMed Capital GP VII LLCDirector, 10% Owner P Buy2023-05-022023-05-0258,826$2.67 $157.1K794,368SEC↗
OrbiMed Capital GP VII LLCDirector, 10% Owner P Buy2023-05-022023-05-02220,610$2.67 $589.0K4,425,462SEC↗
OrbiMed Capital GP VII LLCDirector, 10% Owner P Buy2023-05-022023-05-0258,826$2.67 $157.1K794,368SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-022023-05-0258,826$2.67 $157.1K794,368SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-022023-05-02220,610$2.67 $589.0K4,425,462SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-022023-05-0258,826$2.67 $157.1K794,368SEC↗
OrbiMed Capital GP VII LLCDirector, 10% Owner P Buy2023-05-012023-05-02124,544$2.62 $326.3K735,542SEC↗
OrbiMed Capital GP VII LLCDirector, 10% Owner P Buy2023-05-012023-05-02467,068$2.62 $1.22M4,204,852SEC↗
OrbiMed Capital GP VII LLCDirector, 10% Owner P Buy2023-05-012023-05-02124,545$2.62 $326.3K735,542SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-012023-05-02124,544$2.62 $326.3K735,542SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-012023-05-02124,545$2.62 $326.3K735,542SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-05-012023-05-02467,068$2.62 $1.22M4,204,852SEC↗
OrbiMed Capital GP VII LLCDirector, 10% Owner P Buy2023-04-282023-05-02228,754$2.55 $583.3K3,737,784SEC↗
OrbiMed Capital GP VII LLCDirector, 10% Owner P Buy2023-04-282023-05-0260,997$2.55 $155.5K610,997SEC↗
OrbiMed Capital GP VII LLCDirector, 10% Owner P Buy2023-04-282023-05-0260,998$2.55 $155.5K610,998SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-04-282023-05-0260,998$2.55 $155.5K610,998SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-04-282023-05-02228,754$2.55 $583.3K3,737,784SEC↗
GORDON CARL LDirector, 10% Owner P Buy2023-04-282023-05-0260,997$2.55 $155.5K610,997SEC↗
DeSimone JillDirector A Award deriv2023-03-012023-03-0350,000— $050,000SEC↗
Krishnamohan NehaChief Financial Officer F Tax w/h2023-03-012023-03-031,721$5.21 $9.0K67,378SEC↗
Meltz Mark ACOO General Counsel Secretar F Tax w/h2023-03-012023-03-03638$5.21 $3.3K27,286SEC↗
Williams Richard ThomasChief Medical Officer F Tax w/h2023-03-012023-03-03638$5.21 $3.3K67,295SEC↗
Foresite Capital Management IV10% Owner J Other2023-02-172023-02-221,100,000— $01,975,001SEC↗
Tananbaum James B.Director, 10% Owner J Other2023-02-172023-02-221,100,000— $01,975,001SEC↗
GORDON CARL LDirector, 10% Owner A Award2023-02-172023-02-22550,000— $0550,000SEC↗
GORDON CARL LDirector, 10% Owner A Award2023-02-172023-02-22550,000— $0550,000SEC↗
OrbiMed Genesis GP LLCDirector, 10% Owner A Award2023-02-172023-02-23550,000— $0550,000SEC↗
OrbiMed Genesis GP LLCDirector, 10% Owner A Award2023-02-172023-02-23550,000— $0550,000SEC↗
Farzan NimaChief Executive Officer A Award deriv2023-02-102023-02-14750,000— $0215,000SEC↗
Williams Richard ThomasChief Medical Officer A Award deriv2023-02-102023-02-14215,000— $0215,000SEC↗
Meltz Mark ACOO General Counsel Secretar A Award deriv2023-02-102023-02-14215,000— $0215,000SEC↗
Krishnamohan NehaChief Financial Officer A Award deriv2023-02-102023-02-14215,000— $0215,000SEC↗
Farzan NimaChief Executive Officer A Award deriv2023-02-102023-02-15750,000— $0750,000SEC↗
Meltz Mark ACOO General Counsel Secretar F Tax w/h2022-12-012022-12-02541$7.75 $4.2K27,924SEC↗
Krishnamohan NehaChief Financial Officer F Tax w/h2022-12-012022-12-021,459$7.75 $11.3K69,099SEC↗
Williams Richard ThomasChief Medical Officer F Tax w/h2022-12-012022-12-02541$7.75 $4.2K67,933SEC↗
Meltz Mark ACOO General Counsel Secretar A Award2022-09-012022-09-0225,000— $028,465SEC↗
Krishnamohan NehaChief Financial Officer A Award2022-09-012022-09-0267,500— $069,015SEC↗
Williams Richard ThomasChief Medical Officer A Award2022-09-012022-09-0225,000— $068,474SEC↗
Epperly Melissa B,Director A Award deriv2022-06-132022-06-1520,250— $020,250SEC↗
Smaldone Alsup LaurieDirector A Award deriv2022-06-132022-06-1520,250— $020,250SEC↗
Rome Michael EDirector A Award deriv2022-06-132022-06-1520,250— $020,250SEC↗
GORDON CARL LDirector A Award deriv2022-06-132022-06-1520,250— $020,250SEC↗
Tananbaum James B.Director A Award deriv2022-06-132022-06-1520,250— $020,250SEC↗
MITCHELL DEAN JDirector A Award deriv2022-06-132022-06-1520,250— $020,250SEC↗
Flaherty Keith T.Director A Award deriv2022-06-132022-06-1520,250— $020,250SEC↗
Sabzevari HelenDirector A Award deriv2022-06-132022-06-1520,250— $020,250SEC↗
Williams Richard ThomasChief Medical Officer P Buy2022-03-142022-03-1525,000$8.37 $209.2K42,333SEC↗
Williams Richard ThomasChief Medical Officer P Buy2022-03-112022-03-1515,000$8.64 $129.6K17,333SEC↗
OrbiMed Genesis GP LLCDirector P Buy2022-02-152022-02-159,000$9.96 $89.6K3,509,030SEC↗
GORDON CARL LDirector P Buy2022-02-152022-02-159,000$9.96 $89.6K3,509,030SEC↗
OrbiMed Genesis GP LLCDirector P Buy2022-02-142022-02-1510,000$9.89 $98.9K3,500,030SEC↗
OrbiMed Genesis GP LLCDirector P Buy2022-02-142022-02-1520,700$9.98 $206.6K3,490,030SEC↗
GORDON CARL LDirector P Buy2022-02-142022-02-1510,000$9.89 $98.9K3,500,030SEC↗
GORDON CARL LDirector P Buy2022-02-142022-02-1520,700$9.98 $206.6K3,490,030SEC↗
Williams Richard ThomasChief Medical Officer A Award deriv2022-02-112022-02-15135,000— $0135,000SEC↗
Farzan NimaChief Executive Officer A Award deriv2022-02-112022-02-15400,000— $0400,000SEC↗
Krishnamohan NehaChief Financial Officer A Award deriv2022-02-112022-02-15185,000— $0185,000SEC↗
Meltz Mark ACOO General Counsel Treasure A Award deriv2022-02-112022-02-15135,000— $0135,000SEC↗
OrbiMed Genesis GP LLCDirector P Buy2022-02-112022-02-15156,000$10.22 $1.59M3,469,330SEC↗
GORDON CARL LDirector P Buy2022-02-112022-02-15156,000$10.22 $1.59M3,469,330SEC↗
Sabzevari HelenDirector A Award deriv2021-06-242021-06-2840,501— $040,501SEC↗
Epperly Melissa B,Director A Award deriv2021-06-112021-06-1420,250— $020,250SEC↗
Flaherty Keith T.Director A Award deriv2021-06-112021-06-1420,250— $020,250SEC↗
Smaldone Alsup LaurieDirector A Award deriv2021-06-112021-06-1420,250— $020,250SEC↗
MITCHELL DEAN JDirector A Award deriv2021-06-112021-06-1420,250— $020,250SEC↗
Krishnamohan NehaChief Financial Officer A Award deriv2021-06-072021-06-08270,000— $0270,000SEC↗
Farzan NimaChief Executive Officer A Award deriv2021-02-122021-02-16275,000— $0275,000SEC↗
Meltz Mark ACOO General Counsel Treasure A Award deriv2021-02-122021-02-16100,000— $0100,000SEC↗
Murphy Eric AnthonyChief Scientific Officer A Award deriv2021-02-122021-02-1660,000— $060,000SEC↗
Williams Richard ThomasChief Medical Officer A Award deriv2021-02-122021-02-16100,000— $0100,000SEC↗
Foresite Capital Management IV10% Owner C Conversion deriv2020-12-072020-12-0948,376— $00SEC↗
Foresite Capital Management IV10% Owner C Conversion deriv2020-12-072020-12-09145,128— $00SEC↗
Foresite Capital Management IV10% Owner C Conversion deriv2020-12-072020-12-09157,222— $00SEC↗
Foresite Capital Management IV10% Owner C Conversion deriv2020-12-072020-12-0918,641— $00SEC↗
Foresite Capital Management IV10% Owner C Conversion deriv2020-12-072020-12-0955,922— $00SEC↗
Foresite Capital Management IV10% Owner C Conversion deriv2020-12-072020-12-092,666,002— $00SEC↗
Foresite Capital Management IV10% Owner C Conversion deriv2020-12-072020-12-0999,488— $00SEC↗
Foresite Capital Management IV10% Owner C Conversion deriv2020-12-072020-12-09298,465— $00SEC↗
Foresite Capital Management IV10% Owner C Conversion deriv2020-12-072020-12-096,347,893— $00SEC↗
Tananbaum James B.Director, 10% Owner C Conversion deriv2020-12-072020-12-096,347,893— $00SEC↗
Tananbaum James B.Director, 10% Owner C Conversion deriv2020-12-072020-12-0999,488— $00SEC↗
Tananbaum James B.Director, 10% Owner C Conversion deriv2020-12-072020-12-092,666,002— $00SEC↗
Tananbaum James B.Director, 10% Owner C Conversion deriv2020-12-072020-12-0955,922— $00SEC↗
Tananbaum James B.Director, 10% Owner C Conversion deriv2020-12-072020-12-0918,641— $00SEC↗
Tananbaum James B.Director, 10% Owner C Conversion deriv2020-12-072020-12-09157,222— $00SEC↗
Tananbaum James B.Director, 10% Owner C Conversion deriv2020-12-072020-12-09145,128— $00SEC↗
Tananbaum James B.Director, 10% Owner C Conversion deriv2020-12-072020-12-0948,376— $00SEC↗
Tananbaum James B.Director, 10% Owner C Conversion deriv2020-12-072020-12-09298,465— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2020-12-072020-12-09118,398— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2020-12-072020-12-099,461— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2020-12-072020-12-0950,501— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2020-12-072020-12-0924,555— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2020-12-072020-12-09243,494— $00SEC↗
GORDON CARL LDirector, 10% Owner C Conversion deriv2020-12-072020-12-092,651,042— $00SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion deriv2020-12-072020-12-09118,398— $00SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion deriv2020-12-072020-12-0924,555— $00SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion deriv2020-12-072020-12-099,461— $00SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion deriv2020-12-072020-12-0950,501— $00SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion deriv2020-12-072020-12-092,651,042— $00SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion deriv2020-12-072020-12-09243,494— $00SEC↗
Foresite Capital Management IV10% Owner C Conversion2020-12-072020-12-099,171,643— $09,671,643SEC↗
Foresite Capital Management IV10% Owner C Conversion2020-12-072020-12-09166,667— $0291,667SEC↗
Foresite Capital Management IV10% Owner C Conversion2020-12-072020-12-09500,001— $0875,001SEC↗
Tananbaum James B.Director, 10% Owner C Conversion2020-12-072020-12-09166,667— $0291,667SEC↗
Tananbaum James B.Director, 10% Owner C Conversion2020-12-072020-12-099,171,643— $09,671,643SEC↗
Tananbaum James B.Director, 10% Owner C Conversion2020-12-072020-12-09500,001— $0875,001SEC↗
GORDON CARL LDirector, 10% Owner C Conversion2020-12-072020-12-09118,794— $03,313,330SEC↗
GORDON CARL LDirector, 10% Owner C Conversion2020-12-072020-12-0950,501— $050,501SEC↗
GORDON CARL LDirector, 10% Owner C Conversion2020-12-072020-12-092,651,042— $03,194,536SEC↗
GORDON CARL LDirector, 10% Owner C Conversion2020-12-072020-12-099,461— $059,962SEC↗
GORDON CARL LDirector, 10% Owner C Conversion2020-12-072020-12-09243,494— $0543,494SEC↗
GORDON CARL LDirector, 10% Owner C Conversion2020-12-072020-12-0924,637— $084,599SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion2020-12-072020-12-099,461— $059,962SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion2020-12-072020-12-0924,637— $084,599SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion2020-12-072020-12-0950,501— $050,501SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion2020-12-072020-12-09118,794— $03,313,330SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion2020-12-072020-12-092,651,042— $03,194,536SEC↗
ORBIMED CAPITAL LLCDirector, 10% Owner C Conversion2020-12-072020-12-09243,494— $0543,494SEC↗
Foresite Capital Management IV10% Owner A Award2020-12-032020-12-04125,000$20.00 $2.50M125,000SEC↗
Foresite Capital Management IV10% Owner A Award2020-12-032020-12-04500,000$20.00 $10.00M500,000SEC↗
Foresite Capital Management IV10% Owner A Award2020-12-032020-12-04375,000$20.00 $7.50M375,000SEC↗
Tananbaum James B.Director, 10% Owner P Buy2020-12-032020-12-04500,000$20.00 $10.00M500,000SEC↗
Tananbaum James B.Director, 10% Owner P Buy2020-12-032020-12-04375,000$20.00 $7.50M375,000SEC↗
Tananbaum James B.Director, 10% Owner P Buy2020-12-032020-12-04125,000$20.00 $2.50M125,000SEC↗
GORDON CARL LDirector, 10% Owner A Award deriv2020-12-022020-12-0440,501— $040,501SEC↗
Rome Michael EDirector A Award deriv2020-12-022020-12-0440,501— $040,501SEC↗
Tananbaum James B.Director, 10% Owner A Award deriv2020-12-022020-12-0440,501— $040,501SEC↗
GORDON CARL LDirector, 10% Owner P Buy2020-12-022020-12-04300,000$20.00 $6.00M300,000SEC↗
GORDON CARL LDirector, 10% Owner P Buy2020-12-022020-12-04450,000$20.00 $9.00M450,000SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner P Buy2020-12-022020-12-04450,000$20.00 $9.00M450,000SEC↗
ORBIMED ADVISORS LLCDirector, 10% Owner P Buy2020-12-022020-12-04300,000$20.00 $6.00M300,000SEC↗